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Table 2
Possible IBD Distributions and Their Probabilities at a Marker Locus with r(f ,f ,f )0 1 2
Equifrequent Alleles
IBD
DISTRIBUTION
PROBABILITY
No Linkage Dominant Modela Recessive Modela
(1,0,0) 3 2r  2r  1
34r
3 2 4 3 2r  2r  1 p  4p  4p
#
34r PASP,dom
3 2 4r  2r  1 p
#
34r PASP,rec
(0,1,0) 2(r 1)
22r
2 3 2(r 1) p  p  p
#
22r PASP,dom
2 3(r 1) p
#
22r PASP,rec
(0,0,1) 3 2r  2r  1
34r
3 2 2r  2r  1 p  2p
#
34r PASP,dom
3 2 2r  2r  1 p
#
34r PASP,rec
1 1
, ,0( )2 2 r 12r 4 3 2r 1 p  5p  5p  p#2r 2PASP,dom 4 3r 1 p  p#2r 2PASP,rec
1 1
,0,( )2 2 r 132r 4 3 2r 1 p  4p  3p  2p#32r 2PASP,dom 4 2r 1 p  p#32r 2PASP,rec
1 1
0, ,( )2 2 r 12r 3r 1 p  3p#2r 2PASP,dom 3 2r 1 p  p#2r 2PASP,rec
1 1 1
, ,( )4 2 4 12r 12r 12r
NOTE.—IBD distributions and their probabilities are derived from tables 3 and 5 of
Suarez et al. (Ann Hum Genet 42:87–94) and Risch (Am J Hum Genet 46:242–253),
respectively. The diallelic trait locus has a minor-allele frequency of p.
a Where and .1 14 3 2 4 3 2P p (p  6p  5p  4p) P p (p  2p  p )ASP,dom ASP,rec4 4
In the August 2005 issue of the Journal, in the article
entitled “Weighting Affected Sib Pairs by Marker Infor-
mativity” by Franke and Ziegler (77:230–241), the prob-
abilities for identical-by-descent (IBD) distributions of
affected sib pairs do not reﬂect the intended dominant
and recessive genetic models; instead, they reﬂect com-
pletely different probability distributions that have no
obvious genetic interpretation. The probabilities under
the assumption of no linkage also contain a typograph-
ical error. The corrected table 2 shown here displays the
corrected probabilities, which have been derived using
the well-established results of Suarez et al. (Ann Hum
Genet 42:87–94) and Risch (Am J Hum Genet 46:242–
253). The authors are grateful to Michael Knapp for
pointing out these errors.
The incorrect probabilities for IBD distributions under
linkage substantially inﬂuence the power of both the stan-
dard and the weighted mean test. In fact, new Monte
Carlo simulation studies with the correct IBD probabil-
ities (table 2) show no increase in power of the weighted
compared with the classical mean test for a fully pene-
trant autosomal dominant trait without phenocopies (re-
sults not shown). However, the increased power of the
weighted over the classical mean test is correct for those
genetic models that were reported in table 4 of the orig-
inal article.
Table 1 of the original article displays the mapping
rules for empirical P values; both instances of 24r  1
should be . The exemplary computation on page24d  1
235 is correct for the IBD distribution
  6 2 10 9 10 9 10
fp , ,( )24 24 24
rather than for /2, 1/4, 1/4). On page 237, the IBDfp (1
distribution of the sample data should be speciﬁed as
rather than ,(f ,f ,f )p (0.44,0.5,0.06) f p 0.44 f p0 1 2 2 1
, and . Furthermore, as pointed out by0.44 f p 0.060
Ritwik Sinha, there is a typographical error in the for-
mula on page 233, before equation (2). The variance of
should readtˆ¯w
n
2 2¯ˆw (t tˆ ) . i i wip1
Finally, the authors misinterpreted Risch (Am J Hum
Genet 46:242–253), and the IBD distributions of his
example slightly deviate from those reported in table 5
of the article by Franke and Ziegler. The results, how-
ever, are only marginally inﬂuenced. Details are available
on request.
The authors have been asked by colleagues whether
the empirical P values of the example data reﬂect the same
substantial LOD score differences between the weighted
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and the classical mean tests. Therefore, using their novel
simulation approach, the authors conductedMonteCarlo
simulations for both test statistics. Whereas the P values
are signiﬁcantly lower for the weighted mean test with
use of the data of Mein et al. (Nat Genet 19:297–300)
and the fully informative data of Risch (Am J Hum Ge-
net 46:242–253), P values are virtually identical when
all families are considered in the data of Risch (Am
J Hum Genet 46:242–253). Details are available on
request.
The authors regret the errors.
In the February 2006 issue of the Journal, in the article
entitled “Single-Nucleotide Polymorphisms in NAG-
NAG Acceptors Are Highly Predictive for Variations
of Alternative Splicing” by Hiller et al. (78:291–302),
table 6 did not include the authors’ most-current data.
In the course of ﬁnalizing the study analysis, the au-
thors identiﬁed a set of false-positive dbSNP entries;
see the “Results” section: “Since dbSNP entries some-
times are the result of sequencing errors, we manually
examined the trace data (if available) and excluded
a further nine SNPs” (p. 294). These nine dbSNP en-
tries in table 2 had the footnote “dbSNP entry is based
on a sequencing error; therefore, excluded from fur-
ther analysis and table 6.” Inconsistent with that, two
false-positive SNPs (rs12042060 affecting FIBL-6 and
rs1833783 affecting FTL) were not removed from table
6. The correct table 6, shown here, contains 18 instead
of 20 entries and is thus consistent with the statement
in the “Discussion” section: “Altogether, 28% (18 of
64) of the plausible NAGNAG SNPs occur in known
disease genes (table 6)” (p. 300). The authors regret the
error.
Table 6
Human Disease Genes with SNPs Affecting Plausible NAGNAG Acceptors
dbSNP ID Gene Symbol RefSeq ID Disease MIM Number(s) PubMed ID(s)
rs3020724 CYP17A1 NM_000102 Adrenal hyperplasia, congenital #202110, *609300 4303304
rs2243187 IL19 NM_153758 Asthma *605687 15557163
rs8176139 BRCA1 NM_007304 Breast cancer *113705, #114480 9167459
rs11567804 C3AR1 NM_004054 Bronchial asthma *605246 15278436
rs3025420 DBH NM_000787 Congenital dopamine-beta-hydroxylase deﬁciency #223360, *609312 14991826
rs2409496 GART NM_175085 Down syndrome *138440 9328467
rs1804783 CACNA1A NM_023035 Episodic ataxia-2, familial hemiplegic migraine, spinocerebellar
ataxia-6, idiopathic generalized epilepsy
#183086, #141500, #108500, *601011 8988170, 8898206, 9302278
rs2010657 GGT1 NM_013421 Glutathionuria 231950 238530, 7623451
rs2307130 AGL NM_000644 Glycogen storage disease type III 232400 9032647, 10925384
rs11661706 EPB41L3 NM_012307 Meningioma, lung cancer *605331 10888600, 9892180
rs2275992 ZFP91 NM_170768 Acute myeloid leukemia #601626 12738986
rs1071716 TPM2 NM_213674 Nemaline myopathy-4, distal arthrogryposis 1 #609285, #108120, *190990 11738357, 12592607
rs2521612 SLC4A1 NM_000342 Renal tubular acidosis, ovalocytosis, spherocytosis #179800, 166900, 109270 9600966, 1737855, 9973643
rs9644946 GOLGA1 NM_002077 Sjogren syndrome 270150, *602502 9324025
rs17173698 PAPSS2 NM_004670 Spondyloepimetaphyseal dysplasia *603005 9714015
rs9606756 TCN2 NM_000355 Transcobalamin II deﬁciency 275350 14632784
rs7862221 TSC1 NM_000368 Tuberous sclerosis #191100, *605284 12773162, 14551205
rs11574323 WRN NM_000553 Werner syndrome #277700, *604611 9012406, 8968742
